Roche Bay PlcGrey Market
RCHBF is defunct.
  • Mar. 5, 2014, 7:26 AM
    • The Italian Competition Authority has fined Novartis (NVS) €92M and Roche (RHHBY) €90.5M for forming a cartel to push doctors to prescribe their jointly marketed and more expensive Lucentis therapy to treat vision problems instead of Roche's Avastin, which is older and far cheaper.
    • The agency accused the companies of portraying Avastin as riskier than Lucentis in order to influence prescriptions.
    • Both firms said they would appeal.
    • Novartis and Roche could face further problems if the EU looks into the case and finds that the collusion extended beyond Italy.
    | Mar. 5, 2014, 7:26 AM | 1 Comment